Brief: Pasithea Therapeutics Announces Successful Treatment Of First Patients In The UK With Ketamine Infusion Therapy
27/10/2021 13:00
Oct 27 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS ANNOUNCES SUCCESSFUL TREATMENT OF
FIRST
PATIENTS IN THE UK WITH KETAMINE INFUSION THERAPY
Source text for Eikon: ID:nGNX6xtSNK
Further company coverage: KTTA.O
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement